glp-1 analog weight loss Glucagon-like peptide-1 receptor agonists and muscle mass effects Weight loss with GLP-1 medicines

References Karacabeyli D, Lacaille D

Heart failure and MEF2 transcriptome dynamics in response to -blockers

Another 2024 study found that people with breast cancer and type 2 diabetes taking GLP-1 drugs had fewer major cardiovascular problems (conditions related to heart and blood vessels) after receiving cardiotoxic breast cancer treatments such as anthracyclines and HER2 inhibitors, compared to people not taking GLP-1 drugs

Mejora de la salud mitocondrial y la produccin de energa : Como componente clave de la proteccin mitocondrial, el glutatin ayuda a prevenir el dao oxidativo mitocondrial y mantiene la eficiencia de la sntesis de ATP

The GIP Receptor Pathway Glucose-dependent insulinotropic polypeptide (GIP) is another gut hormone that Tirzepatide targets

Nat Genet 2010